MedPath

Study of Helicobacter pylori eradication therapy using vonopraza

Not Applicable
Completed
Conditions
Helicobacter infection
Registration Number
JPRN-UMIN000019158
Lead Sponsor
Tsuyama Chuo Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
2000
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who received eradication therapy more than once Allergy for the study drugs Patients in need treatment with PPI Postoperative stomach Routine use of anticoagulant or low-dose aspirin, NSAIDS, steroids Severe major organ dysfunction

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath